$SINGAPORE AIRLINES LTD(C6L.SI)$Air travel will not return to pre-Covid levels for the time beingSpeaking on managing the risks brought by the pandemic to changes in the supply chain, Wong said while there was "some impact" in the form of localised disruptions last year, the system has been "resilient" for the most part throughout the pandemic, and has been able to "adjust and cope".However, on the prospects of air travel, he is "somewhat less sanguine" as compared to the outlook on supply chains and trade.Besides the waves of infection the region is seeing, he added that vaccination rates for many countries regionally are "still not high enough".But there might be some travel arrangements made among countries with low and stable infections, he sai
$Virgin Galactic(SPCE)$When trading hype stocks its best to lock in profits and not buy on the days of the news release. Because the market is easily manipulated and people tend to buy the rumours and sell the news. Businessesalso tend to sell shares on the day which everyone expects the stock to rocket, but in fact does not, because this is a great way for the company to raise capital. Yes, by selling shares at the overvalued price and hurting retail investors but benefiting the company in the long run.
$NVIDIA Corp(NVDA)$whole week of good news, great YOY gains, upcoming stock splits, more involvement in the AI+crpyto industry which is currently booming. This is a great buy, especially with the stock split which may potentially drive the stock price up as much as 50-100% when we take a look at big names such asAAPL and TSLA which had similar event that happened. Strong buy and hold for me. Are youguys getting in or out of the game?
$Aerpio Pharmaceuticals Inc(ARPO)$BREAKING NEWS!RA Capital Management, a private fund company who specialises in investing in public healthcare sectors just took up a 5% stake in ARPO on 13 July 2020.
$Aerpio Pharmaceuticals Inc(ARPO)$Just hodl. 1. Upcoming merger will be in favour of the company2. Consolidation for a bull run on hourly chart3. Short will have to cover when the stock rallies4. Michael hurry who once was a physician even bought up a 10% stake in the company5. Ongoing phase 2 clinical trials will read out in late 2021. If approved for the next phase, it will definitely lead to a breakthrough6. The shorts are pushing arpo down and forcing out the paper hands. Don’t be a paper hand! Get use to seeing red, otherwise move on to stocks like APPL to gain 10% a year.
$NIO Inc.(NIO)$NIO delivered 8,083 vehicles in June 2021, increasing by 116.1% year-over-yearNIO delivered 21,896 vehicles in the three months ended June 2021, increasing by 111.9% year-over-yearCumulative deliveries of the ES8, ES6 and EC6 as of June 30, 2021 reached 117,597
$Aerpio Pharmaceuticals Inc(ARPO)$no bad news from the meeting. In fact, the potential NDA approval from the FDA in the coming months might set ARPO up for a HUGE run. Havingpassed trial 1 & 2 is no easy task. But ARPO has already done so with its groundbreaking FYARRO technology which can potentially help with cancer and many other diseases, so the potential is limitless!
$Nikola Corporation(NKLA)$Waiting for breakout! All positive catalyst!1. CNH Industrial and Nikola partnership2. Nikola makes $50 million hydrogen fuel cellinvestment in Midwestern US3 Trial production begins in Germany4. Biden’s $2.3 billion infrastructure plan will benefit the hydrogen tech industry heavily